Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
06/2003
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030108955 Dioxin derivatives and method of measurement therewith
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317490A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
06/11/2003EP1317440A1 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl)acetic acid derivatives
06/11/2003EP1317439A1 Acid-sensitive compounds, preparation and uses thereof
06/11/2003CN1422844A Intermediate for preparing substitated biphenyl oxazoline compounds
06/10/2003US6576776 Method of manufacture of 1,3-oxathiolane nucleosides
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/05/2003WO2003046086A1 New fluorescent pigments
06/05/2003US20030105132 N-phenpropylcuclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/04/2003EP1316554A1 Acetal derivatives of 2-methyl-2secbutyl-1,3-propandiol and their use as fragrance
06/04/2003EP1316553A1 Fragrances based on cyclic acetals
06/04/2003EP1049666B1 Novel naphthyl-substituted and anilide-substituted sulfonamides
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP0862545B1 Pesticide compounds, compositions and process for the preparation thereof
06/04/2003CN1110491C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
06/04/2003CN1110473C Method for removing contaminants from products
06/03/2003US6573378 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine having a purity of greater than 95% by weight or it's sodium salt
05/2003
05/30/2003WO2003044065A2 Microstructure modifier for anionic polymerization
05/30/2003WO2002070509A3 Antagonists of mcp-1 function and methods of use thereof
05/29/2003US20030100772 Oxygen-containing heterocyclic compounds
05/29/2003US20030100580 Benzenesulfonamide derivatives; for treatment of cardiovascular disorders
05/28/2003EP1313754A1 Nucleophile-stable thioester generating compounds, methods of production and use
05/28/2003EP1313741A2 Fluorinated and alkylated alditol derivatives and polyolefin articles containing same
05/28/2003EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
05/27/2003US6569989 Process for producing lactide and process for producing polylactic acid from fermented lactic acid employed as starting material
05/27/2003US6569897 Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
05/27/2003US6569882 Viricides; enzyme inhibitors
05/22/2003WO2003042168A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PHENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042167A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003041728A1 Novel phenyl-propargylether derivatives
05/22/2003US20030096811 Such as cis-(4-dimethylaminomethyl-3-hydroxy-3-(3-methoxy-phenyl)-cyclohexanone for treatment of pain, inflammation, allergies, depression, drug/alcohol abuse, gastritis, itching, cardiovascular/repiratory diseases, epilepsy, and diarrhea
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003CA2464775A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
05/21/2003EP1312601A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
05/21/2003CN1109029C oxygenic heterocyclic compounds
05/20/2003US6566566 Dimerization of a C6-12 olefin mixture in which the hexene isomer fraction has less than 30% by weight of linear isomers in the presence of a nickel catalyst; derivatization to give primary alcohols, and optional subsequent alkoxylation
05/20/2003US6566550 Substituted aromatic ethers as inhibitors of glycine transport
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040074A1 Liquid crystalline compounds containing a biphenyl core
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/14/2003EP1310496A1 Process for the preparation of cyclic esters and method for purification of the same
05/14/2003CN1418210A Carbocyclik side chain containing, N-substituted Metalloprotease inhibitors
05/14/2003CN1418209A Carbocyclic side chain containing metalloprotease inhibitors
05/13/2003US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
05/08/2003US20030087957 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
05/08/2003US20030087882 Antiinflammatory agents
05/07/2003EP1307579A2 Bio-intermediates for use in the chemical synthesis of polyketides
05/07/2003EP1307460A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
05/07/2003EP0889863B1 Surface modified carbonate materials
05/06/2003US6559144 Integrin inhibitors used to treat circulatory disorders, for thrombosis, myocardial infarct, coronary heart disease, arteriosclerosis, osteoporosis, pathological processes maintained or propagated by angiogenesis and tumor therapy
05/02/2003EP1305305A1 Hyperpolarizable organic chromophores
05/02/2003EP1056739B1 Novel cyclic pro-perfumes having modifiable fragrance raw material alcohol release rate
05/02/2003EP1025082B1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
05/01/2003WO2003014063A3 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof
05/01/2003WO2003004459A3 Process for the preparation of nitrile compounds
05/01/2003US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
04/2003
04/30/2003CN1414963A Novel heteroary derivatives, their preparation and use
04/30/2003CN1107060C Piperazingl cyclohexanols and compositions containing same and use thereof
04/29/2003US6555695 Reacting catechol with a base in a hydrocarbon solvent; refluxing to dehydrate; adding polyethylene glycol as a phase transfer catalyst, 2,3-dibromopropionate, and an antifoam agent; intermediate for hypotensive agent, Doxazoxin
04/29/2003US6555685 Preparing purine derivatives, such as famiciclovir and penciclovir, by reacting, in the presence of a palladium catalyst and ligand; by-product inhibition; efficiency
04/29/2003US6555287 Non-subliming, difunctionalized ultraviolet dyes for use in anti-reflective coatings
04/24/2003WO2002079124A3 Method of producing high yield alditol acetals with mineral acids and surfactants
04/24/2003US20030078265 Inhibitors of nitric oxide synthase (nos)
04/24/2003US20030078261 Prostaglandin agonists
04/24/2003US20030077405 Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices
04/23/2003EP1303580A1 Marine oils with reduced levels of contaminants
04/23/2003EP1303520A1 Therapeutic compounds and methods
04/23/2003EP1303503A2 Aniline derivatives
04/23/2003EP1303479A2 7-, 8- and 9-substituted tetracycline compounds
04/23/2003EP1077975B1 Water soluble azoles as broad-spectrum antifungals
04/23/2003CN1106371C Liquid crystal compounds having perfluoroether terminal portions
04/17/2003WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
04/17/2003US20030073847 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
04/17/2003US20030073680 Therapy for Tay-sach, Gaucher diseases
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/16/2003EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
04/16/2003EP1301458A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis
04/16/2003EP1067127B1 Novel beta-diketone compounds, beta-diketone compounds coordinated to metal, method of organic synthesis with these, and catalyst
04/16/2003EP0971913B1 Process for the production of semi synthetic statins via novel intermediates
04/16/2003CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors
04/15/2003US6548674 Amido compounds and process for producing the same
04/15/2003US6548548 Cardiovascular disorders; anticholesterol agents
04/10/2003WO2003029195A1 Intermediates for epothilone derivative and process for producing these
04/10/2003WO2003029184A1 Diaryl ether derivative, addition salt thereof, and immunosuppressant
04/10/2003WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003US20030066988 Electroconductivity coloring
04/09/2003EP1299354A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
04/08/2003US6545108 Catalysts containing N-pyrrolyl substituted nitrogen donors
04/08/2003US6544945 Cyclic pro-perfumes having modifiable fragrance raw material alcohol release rates
04/08/2003US6544602 Supertwist liquid-crystal displays and liquid-crystal mixtures therefor
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 103